ASA committee chair discusses opiate biomarker that shows fentanyl's effect on the brain

On Medscape, David Dickerson, M.D., chair of ASA’s Committee on Pain Medicine, was quoted in an article regarding new research that shows a unique electroencephalogram (EEG) signature produced by fentanyl that allowed researchers to track the drug’s effect on patients. "The development of a fentanyl signature on EEG creates an interesting avenue for sedation monitoring in patients under anesthesia in the operating room or ICU and could help us better titrate fentanyl in these settings to the optimal dose," he said.